Jul 2026
EF-1α-driven nanobody-based CD19-redirected CAR-T cells retain the antitumor efficacy, antigen-driven expansion, and cytokine secretion of CMV-driven counterparts
EF-1α preserved the antitumor potency of nanobody-based CD19-redirected CAR-T cells, supporting its use as a clinically relevant promoter for further development of this VHH-based CAR-T cell platform.
Marzieh Mazinani, Pooria Safarzadeh Kozani, F. Rahbarizadeh
· Molecular and Cellular Bioch... · 0 citations